Workplace Drug‑Testing

The global workplace drug‑testing market is estimated at $15.4 billion, driven by regulatory requirements across these sectors. MindBio’s technology targets this market, providing faster and less invasive alternatives that could transform regulatory enforcement, workplace safety, and public health outcomes.